3rd Jul 2007 07:01
Advanced Medical Solutions Grp PLC03 July 2007 For immediate release 3 July 2007 Advanced Medical Solutions Group plc ("AMS" or "the Group") Directors purchase of shares Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalmedical technology company, announces today that Geoffrey Vernon, Chairman, haspurchased 100,000 Ordinary Shares at 20.5p; Don Evans, Chief Executive Officer,has purchased 20,000 shares at 20.25p; Chris Meredith, Commercial Director, haspurchased 10,000 shares at 20.25p and Steve Bellamy, non-Executive Director, haspurchased 100,000 shares at 20.25p . As a result, Geoffrey Vernon has a beneficial and non beneficial interest in960,000 ordinary shares, representing 0.67% of the issued share capital of theCompany; Don Evans has a beneficial and non beneficial interest in 763,859ordinary shares, representing 0.53% of the issued share capital of the Company;Chris Meredith has a beneficial and non beneficial interest in 55,136 ordinaryshares, representing 0.04% of the issued share capital of the Company and SteveBellamy has a beneficial and non beneficial interest in 100,000 ordinary shares,representing 0.07% of the issued share capital of the Company. For further information, please contact: Advanced Medical Solutions Group plcDon Evans, Chief Executive Officer Tel: +44 (0) 1606 545508Mary Tavener, Finance Directorwww.admedsol.com Buchanan CommunicationsMark Court, Mary-Jane Johnson Tel: +44 (0) 20 7466 5000 Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $15 billion global woundcare market. Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on thedesign, development and manufacture of innovative and technologically advancedproducts for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove a product from design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing topical wounds sold direct to hospitals or throughdistributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group